Not applicableUnknownNCT05383014What this trial is testingFLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Who this might be right forAcute Myeloid Leukemia Assiut University 82
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Not applicableStudy completedNCT02598752What this trial is testingFeasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more Memorial Sloan Kettering Cancer Center 11
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Early research (Phase 1)Study completedNCT00602693What this trial is testingT-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)Study completedNCT02125318What this trial is testingAnagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersWho this might be right forThrombocytosisMyeloproliferative Neoplasms Galena Biopharma, Inc. 18
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010What this trial is testingMenin-Inhibitor Targeted Maintenance in AMLWho this might be right forRelapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more Center for International Blood and Marrow Transplant Research 146
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT02639559What this trial is testingSafety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological MalignanciesWho this might be right forAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more Washington University School of Medicine 50
Early research (Phase 1)Study completedNCT01713582What this trial is testingA Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)Who this might be right forAcute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Early research (Phase 1)Active Not RecruitingNCT05362773What this trial is testingMGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forLeukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more MacroGenics 130
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT00867230What this trial is testingFTS Study in Patients With Advanced Hematologic MalignanciesWho this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524530What this trial is testingStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersWho this might be right forCore Binding Factor Alpha SubunitsHematologic NeoplasmsLeukemia+1 more National Cancer Institute (NCI) 102
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center